Armata Pharmaceuticals, Inc. financial statements
Armata Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 4.9M | EODHD |
| Net income | −USD 173.8M | 10-K |
| Cash and equivalents | USD 8.69M | 10-Q |
| Total debt | USD 288.02M | EODHD |
Armata Pharmaceuticals, Inc. financials on 6ix · Armata Pharmaceuticals, Inc. on 6ix